Today's Pre-Market Stock Movers and Top Ratings: TSLA, DKNG, COTY, BCS and More

$Fisker(FSR.US)$ stock rose 3.8% after the EV manufacturer announced that it expects to ramp up deliveries to 300 vehicles per day in U.S. and Europe, having manufactured 5,000 Fisker Oceans to date.

$DraftKings(DKNG.US)$ stock rose 3.1% after JPMorgan upgraded its stance on the betting company to 'overweight' from 'neutral', seeing promising potential for same-store and new market growth.

$Tesla(TSLA.US)$ stock fell 0.8% after the Financial Times reported that the EV manufacturer's export vehicles from China to the European Union will be included in the EU's investigation into whether China's electric vehicle industry is benefiting from unfair subsidies.

$United Natural Foods(UNFI.US)$ stock fell 13% after the organic foods company swings to a loss amid lower inflation benefits.

$Snap Inc(SNAP.US)$ stock fell 1.5% after HSBC initiated coverage of the social media company with a 'reduce' rating, saying a successful turnaround of its core advertising business is unlikely.

$Alibaba(BABA.US)$ ADRs fell 0.3% after the Chinese e-commerce giant announced a plan to list its logistics arm Cainiao in Hong Kong that would make the unit the first to be separated since it announced its break-up six months ago.

$Coty Inc(COTY.US)$ stock fell 3% after the cosmetics maker launched a global offering of 33 million shares and said it had submitted an application for dual listing of its shares on the Paris Stock Exchange.

$Nordson(NDSN.US)$ stock fell 1.5% after Jefferies downgraded its stance on adhesive manufacturing company to 'hold' from 'buy', doubting the company's near-term growth.

$Pinterest(PINS.US)$ initiated at Buy by HSBC, announced target price at $32.

$Barclays(BCS.US)$ was upgraded by Morgan Stanley from Equal-Weight to Overweight.

$DraftKings(DKNG.US)$ was upgraded by JP Morgan from Neutral to Overweight, increased target price from $26 to $37.

$W.P. Carey Inc(WPC.US)$ was downgraded by BMO Capital from Outperform to Market Perform, decreased target price from $75 to $60.